Adult ADHD (Attention-deficit hyperactivity disorder ). Hyperkinetic disorder, unspecified
Conditions
Interventions
Intervention 1: One group of patients are randomly assigned to receive methylphenidate in the intervention group. Methylphenidate 10 mg is prescribed for the first week, a daily tablet (half tablet in
in the second week, two tablets are daily prescribed (one in the morning at 8 o'clock, one at 16 o'clock)
if the weight is above 30 pounds, 3 tablets will be daily prescribed in the second week (one and a half tablet each morning at 8 o'clock, one and a half tablet at 16 o'clock). Therapeutic dosage of om
if the weight is above 30 pounds, 3 tablets will be daily prescribed in the second week (one and a half tablet each morning at 8 o'clock, one and a half tablet at 16 o'clock). Therapeutic dosage of pl
Treatment - Drugs
Placebo
One group of patients are randomly assigned to receive methylphenidate in the intervention group. Methylphenidate 10 mg is prescribed for the first week, a daily tablet (half tablet in morning at 8 o'
Sponsors
Kurdistan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Diagnosis of ADHD based on DSMIV age between 6-12 Exclusion Criteria: receiving of omega3 suplement during past 6 months; presence of seizures; mental retardation; having any psychiatric disorders
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in Attention-deficit symptoms. Timepoint: Baseline, second, fourth and eighth weeks after intervention. Method of measurement: Conner's and ADHD Rating Scales.;Improvement in Impulsivity symptoms. Timepoint: Baseline, third and sixth weeks after intervention. Method of measurement: Conner's and ADHD Rating Scales–Self-Report.;Improvement in hyperactivity symptome. Timepoint: Baseline, third and sixth weeks after intervention. Method of measurement: Conner's and ADHD Rating Scales–Self-Report. | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of ADHD symptoms. Timepoint: Baseline, second, fourth and eighth weeks after intervention. Method of measurement: ADHD Rating Scales, CGI.;Side effect. Timepoint: second, fourth and eighth weeks after intervention. Method of measurement: Side effects quesionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSoleiman Mohammadzadeh
Kurdistan University of Medical Sciences
Outcome results
None listed